Medroxyprogesterone acetate
Medroxyprogesterone acetate is a pharmaceutical drug with 22 clinical trials. Currently 2 active trials ongoing. Historical success rate of 94.4%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
4
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.4%
17 of 18 finished
5.6%
1 ended early
2
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
Clinical Trials (22)
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia
Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer
The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles
Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB
Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women
Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Endometrial Shedding Prior to Ovulation Induction Pilot Study
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women
DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
PK of Depo SubQ Injected in the Upper Arm
Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities
Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women
Somatropin Treatment to Final Height in Turner Syndrome
Hormonal Birth Control and the Risk of Acquiring HIV
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 22